Monday - October 5, 2026

Management of Dermal Neurofibromatosis Lesions

2026-08-18

ALEXANDRIA, Virginia, Aug. 18 -- SUN PHARMACEUTICAL INDUSTRIES, INC., Princeton, New Jersey has been assigned a patent (No. US 12708791 B2, initially filed March 26, 2021) developed by three inventors Harry Thomas Whelan, Whitefish Bay, Wisconsin; Brendan John Quirk, Mayville, Wisconsin; and Edit Olasz Harken, Pewaukee, Wisconsin, for "Management of dermal neurofibromatosis lesions." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Management of Dermal Neurofibromatosis Lesions

Information Request Form

Copyright Targeted News Service 2026